| Product Code: ETC7227638 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Prophylactic Vaccines Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 France Prophylactic Vaccines Market - Industry Life Cycle |
3.4 France Prophylactic Vaccines Market - Porter's Five Forces |
3.5 France Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 France Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 France Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 France Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 France Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 France Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of preventive healthcare measures |
4.2.2 Growing prevalence of infectious diseases in France |
4.2.3 Government initiatives to promote vaccination programs |
4.3 Market Restraints |
4.3.1 High costs associated with vaccine development and production |
4.3.2 Regulatory challenges and stringent approval processes |
4.3.3 Vaccine hesitancy and misinformation among the population |
5 France Prophylactic Vaccines Market Trends |
6 France Prophylactic Vaccines Market, By Types |
6.1 France Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 France Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 France Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 France Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 France Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 France Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 France Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 France Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 France Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 France Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 France Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 France Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 France Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 France Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 France Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 France Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 France Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 France Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 France Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 France Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 France Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 France Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 France Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 France Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 France Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 France Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 France Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 France Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 France Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 France Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 France Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 France Prophylactic Vaccines Market Export to Major Countries |
7.2 France Prophylactic Vaccines Market Imports from Major Countries |
8 France Prophylactic Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate among target population groups |
8.2 Number of new vaccine approvals and introductions in the market |
8.3 Research and development investment in new vaccine technologies |
8.4 Adherence to vaccination schedules and recommendations |
8.5 Public health outcomes related to vaccine-preventable diseases |
9 France Prophylactic Vaccines Market - Opportunity Assessment |
9.1 France Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 France Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 France Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 France Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 France Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 France Prophylactic Vaccines Market - Competitive Landscape |
10.1 France Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 France Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here